Targeted Disruption of the Acid α-Glucosidase Gene in Mice Causes an Illness with Critical Features of Both Infantile and Adult Human Glycogen Storage Disease Type II
Nina Raben(APT Therapeutics (United States)), Paul H. Plötz(National Institutes of Health), Jerrold M. Ward(National Institutes of Health), Barry J. Byrne(University of Florida Health), Mary E. LaMarca(National Institutes of Health), Brian Sauer(National Institute of Diabetes and Digestive and Kidney Diseases), Laura Lee(National Institutes of Health), Paul Kessler(Johns Hopkins University), Kanneboyina Nagaraju(Children's National), Eunice Lee(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Christina D. King(Buck Institute for Research on Aging)
Cited by 298
Related Papers
Therapy of Lupus Nephritis
|New England Journal of Medicine|1986|1.2k
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus
|New England Journal of Medicine|1979|531
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
|The Journal of Experimental Medicine|2005|395